Stockreport

Pfenex and Arcellx Announce a Development, Evaluation and License Agreement

PFENEX INC  (PFNX) 
NASDAQ:AMEX Investor Relations: pfenex.com
PDF First Arcellx sparX protein successfully completed process development using Pfenex Expression Technology® platform Second sparX program initiated by Arcellx SAN DIEGO [Read more]